Pancreatic cancer: Intra-tumour bacteria promote gemcitabine resistance in pancreatic adenocarcinoma

  • Hugh Thomas
  • Published 2017 in Nature Reviews Gastroenterology & Hepatology

Abstract

role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science 357, 1156–1160 (2017) Bacteria within tumours could confer resistance to gemcitabine in patients with pancreatic adenocarcinoma (PDAC), reports a new study. The development of resistance to chemotherapy is a substantial hurdle to effectively treating… (More)
DOI: 10.1038/nrgastro.2017.142

Topics

Cite this paper

@article{Thomas2017PancreaticCI, title={Pancreatic cancer: Intra-tumour bacteria promote gemcitabine resistance in pancreatic adenocarcinoma}, author={Hugh Thomas}, journal={Nature Reviews Gastroenterology & Hepatology}, year={2017}, volume={14}, pages={632-632} }